πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 32 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10030061

Hepcidin analogues and uses thereof

Protagonist Therapeutics, Inc. Β· Granted Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10023614

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bow

Protagonist Therapeutics, Inc. Β· Granted Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9822157

Hepcidin analogues and uses thereof

Protagonist Therapeutics, Inc. Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9809623

Ξ±4Ξ²7 peptide monomer and dimer antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9714270

a4B7 integrin thioether peptide antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624268

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bow

Protagonist Therapeutics, Inc. Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9518091

A4B7 peptide monomer and dimer antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273093

Ξ±4Ξ²7 peptide dimer antagonists

Protagonist Therapeutics, Inc. Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted